TELMISTRUM CH 6.25 Mg Tablet : Uses, Benefits, Dosage, Price & Side Effects and more

Telmisartan (40mg), Chlorthalidone (6.25mg)

TELMISTRUM CH 6.25 Mg

Telmisartan and Chlorthalidone combination therapies have gained significant attention for their efficacy in managing hypertension and related conditions. This article delves into the specifics of "TELMISTRUM CH 6.25," combining Telmisartan at 40mg and Chlorthalidone at 6.25mg, exploring its uses, dosage, side effects, precautions, and more.

Uses:

1. Hypertension Management: TELMISTRUM CH 6.25 is primarily prescribed to control high blood pressure, reducing the risk of cardiovascular events.
2. Edema: Chlorthalidone component aids in reducing excess fluid retention, beneficial in conditions like edema.
3. Renal Protection: The combination's mechanism supports renal function, making it valuable in renal impairment cases linked with hypertension.

Dosage:

• Dosage adjustments may be necessary based on individual response and concurrent medications.
• Patients are advised against altering dosages without medical consultation.

Side Effects:

While generally well-tolerated, TELMISTRUM CH 6.25 may cause some side effects, including:

1. Hypotension: Particularly in susceptible individuals or during initial titration phases.
2. Electrolyte Imbalance: Chlorthalidone's diuretic effect can lead to potassium and sodium disturbances.
3. Dizziness or Lightheadedness: Commonly reported during the early stages of treatment.
4. Increased Urination: Resulting from Chlorthalidone's diuretic action.

Precautions:

1. Pregnancy and Lactation: TELMISTRUM CH 6.25 is generally not recommended during pregnancy, especially in the second and third trimesters. Consultation with a healthcare provider is crucial for lactating mothers.
2. Renal Impairment: Caution is advised in patients with renal dysfunction, with dosage adjustments as per renal function.
3. Hepatic Impairment: Close monitoring is necessary in individuals with liver impairment due to potential drug interactions and altered metabolism.

Drug Interactions:

1. Potassium-Sparing Diuretics: Concurrent use may increase the risk of hyperkalemia.
2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Can diminish the antihypertensive effects of TELMISTRUM CH 6.25.
3. Lithium: Chlorthalidone component can elevate lithium levels, requiring dosage adjustments.

Conclusion:

TELMISTRUM CH 6.25, combining Telmisartan and Chlorthalidone, stands as a valuable therapeutic option in managing hypertension and related conditions. Its careful use, under medical supervision, can significantly contribute to cardiovascular health and overall well-being. As with any medication, adherence to prescribed dosages and regular follow-ups with healthcare providers are essential for optimal outcomes. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW